Related Experiment Video
Updated: Mar 15, 2026

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
[Progress in study on endocannabinoids and cannabinoid receptors in the treatment for neuropathic pain]
Peng Liu1, Wei Zhang1, Shaobo Zhang1
1Department of Orthopedics, Second Hospital of Lanzhou University; Key Laboratory of Orthopedics Disease of Gansu Province, Lanzhou 730030, China.
Abstract:
Endocannabinoids and cannabinoid receptors are expressed in various central pain modulation regions. They maintain in dynamic changes in the expression level and distribution under different pathological and physiological conditions. These changes possess advantage as well as disadvantage. Exogenous administration of endocannabinoids exerts analgesic effect in different pain models, which is mainly mediated by the cannabinoid CB1 and CB2 receptors. Inhibition of enzymes for degrading endocannabinoids in different pain models also shows analgesic effect due to the increased local levels of endocannabinoids.
Related Concept Videos
Analgesia and Pain Management
Opioid Receptors: Overview
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Nociception
Pain
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

